Published by Frank Prenesti on 11th September 2023
(Sharecast News) - Syncona shares fell as the UK healthcare investment firm said Novartis had stopped the development of experimental eye treatment, GT005, resulting in milestone payments write-off of £54.5m for Gyroscope Holdings in which Syncona once held a 54% stake.
URL: http://www.digitallook.com/dl/news/story/33760539/...